Treatment profile

LongevityEmerging optionResearch pathways

Young Plasma Infusion

Transfusion of young donor plasma to deliver rejuvenating factors and combat systemic aging

1-2 hours$5,000 - $15,000

This therapy is still emerging. Gabriel can help you understand the evidence and identify legitimate research or waitlist pathways.

Duration and price are catalog estimates. Gabriel verifies the current quote, provider credentials, risks, and availability before booking.

Young Plasma Infusion

A typical visit

Medical screening and baseline labs (inflammatory markers, biological age tests)

Duration

1-2 hours

Listed from

$5,000

Practitioner access

Research-only

Category

Longevity

Local access

Find the right local path.

Choose a city or state. Gabriel will carry it into the search, verify the exact offering, and confirm the facts before you book.

About this treatment

What this treatment is designed to do

Treatment evidence, regulatory status, risks, and expected outcomes vary. This page is educational and does not confirm that the treatment is appropriate, available, or likely to benefit you.

Young plasma infusion is inspired by parabiosis research — seminal experiments at Stanford and Harvard where connecting the circulatory systems of old and young mice reversed aging markers in the older mice. The old mice showed improved muscle repair, brain function, liver regeneration, and reduced inflammation simply from exposure to factors in young blood.

The clinical translation involves infusing plasma from young, healthy donors (typically ages 18-25) into older recipients. The hypothesis is that young plasma contains a cocktail of growth factors, exosomes, and signaling molecules that are depleted with age — and that replenishing these factors can trigger systemic rejuvenation.

Ambrosia, a startup that gained attention in 2019, was one of the first companies to offer young plasma commercially. Since then, the field has evolved: some clinics now combine young plasma with TPE (therapeutic plasma exchange) — first removing old plasma, then replacing with young plasma — for a more powerful reset. Research from Dobri Kiprov, MD and others has shown measurable improvements in inflammatory markers, cognitive function, and biological age.

Visit flow

What happens during the session

1

Medical screening and baseline labs (inflammatory markers, biological age tests)

2

Young donor plasma is rigorously screened for infectious disease and quality

3

Infusion takes 1-2 hours via standard IV

4

Some protocols combine with TPE (remove old plasma first, then infuse young)

5

Mild fatigue possible for 24-48 hours post-infusion

6

Series of 3-5 infusions typically recommended, spaced 2-4 weeks apart

Best for

Why people usually choose this

Longevity enthusiasts pursuing the most advanced anti-aging interventions

Adults 50+ with elevated inflammatory markers and biological age acceleration

Those interested in parabiosis-inspired research translated to clinical practice

High-net-worth individuals comfortable with frontier medicine risk profiles

Key outcomes

What people hope to improve

Inspired by Nobel-worthy parabiosis research from Stanford and Harvard

Delivers young growth factors, exosomes, and signaling molecules systemically

Measurable reductions in inflammatory markers reported in clinical observations

Potential cognitive improvements based on animal model data

Gabriel intelligence

How Gabriel makes this treatment more actionable

Treatment fit

Root-cause context before you book

Gabriel can help decide whether young plasma infusion fits your symptoms, labs, and recovery goals before you spend money on a session.

Protocol pairing

Connect sessions to a real plan

Gabriel can compare this option with your existing care plan, medications, diagnostics, risks, and follow-up needs before any change is proposed.

Practitioner match

Find the right clinic, not just the nearest one

Gabriel uses available directory signals, location, and modality overlap to surface potential matches, then verifies the facts before booking.

Evidence & safety

What to know before committing

Experimental. Parabiosis animal data is strong and reproducible. Human clinical data is limited to observational studies and case series. Standard blood transfusion safety protocols apply. Risks include transfusion reactions (rare with screened plasma). FDA has issued guidance that young plasma is not proven for anti-aging. Pursue only at reputable medical facilities.

Not sure if this treatment is the right next move?

Tell Gabriel what you are dealing with and what you have already tried. You will get a more useful answer than a generic treatment directory can give.